表达FOXP3的树突状细胞在癌症的诊断和治疗中的用途
- 专利权人:
- 成均馆大学校产学协力团
- 发明人:
- 裵容洙,郑理*,姜明昊
- 申请号:
- CN201880027892.0
- 公开号:
- CN110573181A
- 申请日:
- 2018.30.04
- 申请国别(地区):
- CN
- 年份:
- 2019
- 代理人:
- 摘要:
- 提供了从由表达叉头框P3(Foxp3)的树突状细胞和表达分化簇8(CD8)的调节性T细胞组成的组中选择的至少一种作为癌症治疗靶标和/或癌症诊断标记物的用途。
- 来源网站:
- 中国工程科技知识中心
相关发明人
相关专利
- SUMO AS A MARKER OF CANCER DEVELOPMENT AND TARGET FOR CANCER THERAPY
- Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
- Tumor-targeted nanodelivery systems to improve early MRI detection of cancer
- TUMOR-TARGETED NANODELIVERY SYSTEMS TO IMPROVE EARLY MRI DETECTION OF CANCER
- Tumor-targeted nanodelivery system for improving early MRI detection of cancer